Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
61.7M
-
Shares change
-
+39M
-
Total reported value, excl. options
-
$77.2M
-
Value change
-
+$49M
-
Number of buys
-
28
-
Number of sells
-
-19
-
Price
-
$1.25
Significant Holders of REGULUS THERAPEUTICS INC - COM (RGLS) as of Q3 2017
57 filings reported holding RGLS - REGULUS THERAPEUTICS INC - COM as of Q3 2017.
REGULUS THERAPEUTICS INC - COM (RGLS) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.7M shares
.
Largest 10 shareholders include FMR LLC (15.6M shares), BVF INC/IL (12.9M shares), NEA Management Company, LLC (11M shares), EcoR1 Capital, LLC (5.24M shares), Broadfin Capital, LLC (4.29M shares), VANGUARD GROUP INC (2.87M shares), Boxer Capital, LLC (2.2M shares), South Dakota Investment Council (1.82M shares), BlackRock Inc. (809K shares), and Candriam Luxembourg S.C.A. (600K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.